Shares of MDXHealth SA (NASDAQ:MXDHF) have been assigned an average broker rating score of 2.00 (Buy) from the one analysts that cover the company, Zacks Investment Research reports. One research analyst has rated the stock with a buy rating.

Brokers have set a 1 year consensus price target of $7.90 for the company, according to Zacks. Zacks has also given MDXHealth SA an industry rank of 62 out of 265 based on the ratings given to its competitors.

Separately, Zacks Investment Research raised shares of MDXHealth SA from a “hold” rating to a “buy” rating and set a $6.25 price objective for the company in a research report on Friday, September 15th.

ILLEGAL ACTIVITY WARNING: “Zacks: MDXHealth SA (MXDHF) Given $7.90 Consensus Target Price by Analysts” was originally posted by American Banking News and is owned by of American Banking News. If you are viewing this story on another site, it was copied illegally and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this story can be read at https://www.americanbankingnews.com/2017/10/20/zacks-mdxhealth-sa-mxdhf-given-7-90-consensus-target-price-by-analysts.html.

Shares of MDXHealth SA (MXDHF) opened at 5.90 on Friday. The stock’s market cap is $294.70 million. The stock’s 50 day moving average price is $5.87 and its 200 day moving average price is $5.66. MDXHealth SA has a one year low of $4.77 and a one year high of $6.15.

Get a free copy of the Zacks research report on MDXHealth SA (MXDHF)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for MDXHealth SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MDXHealth SA and related companies with MarketBeat.com's FREE daily email newsletter.